NCT00288002View on ClinicalTrials.gov

Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

1,500

Participants

Timeline

Start Date

January 31, 2005

Conditions

Breast Cancer

Interventions

BIOLOGICAL

trastuzumab

DRUG

capecitabine

DRUG

cyclophosphamide

DRUG

docetaxel

DRUG

epirubicin hydrochloride

PROCEDURE

adjuvant therapy

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

Trial Locations (1)

D-63263

Universitaetsfrauenklinik Frankfurt, Neu-Isenburg

All Listed Sponsors

lead

GBG Forschungs GmbH

OTHER

NCT00288002 - Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer | Biotech Hunter | Biotech Hunter